Here, gain- and loss-of-experiments and a series of in vitro and in vivo assays illustrated that NMT1 overexpression contributes to HCC cancer progression through the myristoylation of downstream substrates and the activation of key signaling pathways. The gene discussed is NMT1; the disease is cancer.